While the drop in Ultragenyx stock certainly provides a lower entry point for new investors, the more prudent choice right ...

Pharmaceutical companies have long complained that Europe spends too little on drugs. It took the arrival of Donald Trump — ...

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...

Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...

Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the ...

The bottom line of the company was also affected by a review of its intercompany receivables, resulting in an exceptional ...

Silo Pharma, Inc. (Nasdaq: SILO) ("Silo” or the "Company”), a diversified developmental stage biopharmaceutical and ...

Discover why pharma sector leaders and AI innovation may drive the S&P 500 to 9,000 by 2026. Explore top stocks, growth ...

Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

Aurobindo Pharma said the decision is aligned with CuraTeQ's strategic portfolio prioritisation. As per the arrangement, ...

For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...